|
|
Comments on BX Rulemaking
Order Instituting Proceedings to Determine Whether to Disapprove Proposed Rule Change, as Modified by Amendment No. 1, to Create a Listing Market on the Exchange
(Release No. 34-63448; File No. SR-BX-2010-059)
|
Apr. 19, 2011 | James McCarthy |
Jan. 26, 2011 | William F. Galvin, Secretary of the Commonwealth of Massachusetts |
Jan. 24, 2011 | Rey Ramsey, President and CEO, TechNet |
Jan. 24, 2011 | Michael Trocchio, Bingham McCutchen LLP, on behalf of OTC Markets Group Inc. |
Jan. 21, 2011 | Alan F. Eisenberg, Executive Vice President, Emerging Companies & Business Development, Biotechnology Industry Organization (BIO) |
Jan. 21, 2011 | Mark G. Heesen, President, National Venture Capital Association, Arlington, Virginia |
Jan. 20, 2011 | K. Richard B. Niehoff, Chairman and CEO, United States OTC Markets, Inc. |
Jan. 14, 2011 | James J. Angel, Ph.D., CFA, Associate Professor of Finance, Georgetown University, McDonough School of Business, Washington D.C. |
Notice of Filing of Proposed Rule Change to Create a Listing Market on the Exchange
(Release No. 34-62818; File No. SR-BX-2010-059)
|
Feb. 17, 2011 | Joan Conley, SVP and Corporate Secretary, NASDAQ OMX |
Dec. 1, 2010 | Tom A. Alberg, Managing Director and Founder, Madrona Venture Group |
Oct. 3, 2010 | Michael Trocchio, Bingham McCutchen LLP, on behalf of Pink OTC Markets Inc. |
Sep. 28, 2010 | William F. Galvin, Secretary of the Commonwealth of Massachusetts |
http://www.sec.gov/comments/sr-bx-2010-059/bx2010059.shtml
|